Literature DB >> 25265596

Osteopontin: At the cross-roads of myocyte survival and myocardial function.

Mahipal Singh1, Suman Dalal1, Krishna Singh2.   

Abstract

Heart failure represents a major cause of morbidity and mortality in Western society. Cardiac myocyte loss due to apoptosis plays a significant role in the progression of heart failure. The extracellular matrix (ECM) maintains the structural integrity of the heart and allows the transmission of electrical and mechanical signals during cardiac contraction and relaxation. Matricellular proteins, a class of non-structural ECM proteins, play a significant role in ECM homeostasis and intracellular signaling via their interactions with cell surface receptors, structural proteins, and/or soluble extracellular factors such as growth factors and cytokines. Osteopontin (OPN), also called cytokine Eta-1, is a member of the matricellular protein family. The normal heart expresses low levels of OPN. However, OPN expression increases markedly under a variety of pathophysiological conditions of the heart. Many human and transgenic mouse studies provide evidence that increased OPN expression, specifically in myocytes, is associated with increased myocyte apoptosis and myocardial dysfunction. This review summarizes OPN expression in the heart, and its role in myocyte apoptosis and myocardial function. Published by Elsevier Inc.

Entities:  

Keywords:  Apoptosis; Heart function; Myocytes; Osteopontin

Mesh:

Substances:

Year:  2014        PMID: 25265596      PMCID: PMC4254317          DOI: 10.1016/j.lfs.2014.09.014

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  69 in total

Review 1.  Mitochondria and heart failure: new insights into an energetic problem.

Authors:  L Chen; A A Knowlton
Journal:  Minerva Cardioangiol       Date:  2010-04       Impact factor: 1.347

Review 2.  Structural and functional characterisation of cardiac fibroblasts.

Authors:  Patrizia Camelliti; Thomas K Borg; Peter Kohl
Journal:  Cardiovasc Res       Date:  2005-01-01       Impact factor: 10.787

3.  Osteopontin predicts adverse right ventricular remodelling and dysfunction in pulmonary hypertension.

Authors:  Mark Rosenberg; F Joachim Meyer; Ekkehard Gruenig; Matthias Lutz; Dirk Lossnitzer; Rita Wipplinger; Hugo A Katus; Norbert Frey
Journal:  Eur J Clin Invest       Date:  2012-04-14       Impact factor: 4.686

4.  Extensive induction of important mediators of fibrosis and dystrophic calcification in desmin-deficient cardiomyopathy.

Authors:  Manolis Mavroidis; Yassemi Capetanaki
Journal:  Am J Pathol       Date:  2002-03       Impact factor: 4.307

5.  Myocardial osteopontin expression coincides with the development of heart failure.

Authors:  K Singh; G Sirokman; C Communal; K G Robinson; C H Conrad; W W Brooks; O H Bing; W S Colucci
Journal:  Hypertension       Date:  1999-02       Impact factor: 10.190

6.  Osteopontin is released from the heart into the coronary circulation in patients with a previous anterior wall myocardial infarction.

Authors:  Akira Tamura; Maki Shingai; Nobuko Aso; Takayuki Hazuku; Masaru Nasu
Journal:  Circ J       Date:  2003-09       Impact factor: 2.993

Review 7.  Osteopontin as potential biomarker and therapeutic target in gastric and liver cancers.

Authors:  Dong-Xing Cao; Zhi-Jie Li; Xiao-Ou Jiang; Yick Liang Lum; Ester Khin; Nikki P Lee; Guo-Hao Wu; John M Luk
Journal:  World J Gastroenterol       Date:  2012-08-14       Impact factor: 5.742

8.  Reduced postischemic macrophage infiltration and interstitial fibrosis in osteopontin knockout mice.

Authors:  Veerle P Persy; Anja Verhulst; Dirk K Ysebaert; Kathleen E De Greef; Marc E De Broe
Journal:  Kidney Int       Date:  2003-02       Impact factor: 10.612

Review 9.  ER stress in cardiovascular disease.

Authors:  Tetsuo Minamino; Masafumi Kitakaze
Journal:  J Mol Cell Cardiol       Date:  2009-11-12       Impact factor: 5.000

10.  Osteopontin stimulates apoptosis in adult cardiac myocytes via the involvement of CD44 receptors, mitochondrial death pathway, and endoplasmic reticulum stress.

Authors:  Suman Dalal; Qinqin Zha; Christopher R Daniels; Rebecca J Steagall; William L Joyner; Alain-Pierre Gadeau; Mahipal Singh; Krishna Singh
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-02-14       Impact factor: 4.733

View more
  20 in total

1.  Identification of satellite cells from anole lizard skeletal muscle and demonstration of expanded musculoskeletal potential.

Authors:  Joanna Palade; Djordje Djordjevic; Elizabeth D Hutchins; Rajani M George; John A Cornelius; Alan Rawls; Joshua W K Ho; Kenro Kusumi; Jeanne Wilson-Rawls
Journal:  Dev Biol       Date:  2017-12-25       Impact factor: 3.582

2.  Wogonin suppresses osteopontin expression in adipocytes by activating PPARα.

Authors:  Ye-min Zhang; Ming-xin Li; Zhao Tang; Chang-hua Wang
Journal:  Acta Pharmacol Sin       Date:  2015-06-15       Impact factor: 6.150

3.  Screening for Biomarkers Associated with Left Ventricular Function During Follow-up After Acute Coronary Syndrome.

Authors:  Christina Christersson; Tomasz Baron; Frank Flachskampf; Lars Lindhagen; Bertil Lindahl; Agneta Siegbahn
Journal:  J Cardiovasc Transl Res       Date:  2022-06-21       Impact factor: 4.132

4.  Silencing Survivin: a Key Therapeutic Strategy for Cardiac Hypertrophy.

Authors:  Claudia Kusmic; Alessio Vizzoca; Monia Taranta; Lorena Tedeschi; Lisa Gherardini; Gualtiero Pelosi; Ambra Giannetti; Sara Tombelli; Settimio Grimaldi; Francesco Baldini; Claudio Domenici; Maria Giovanna Trivella; Caterina Cinti
Journal:  J Cardiovasc Transl Res       Date:  2021-08-18       Impact factor: 3.216

5.  Osteopontin-stimulated apoptosis in cardiac myocytes involves oxidative stress and mitochondrial death pathway: role of a pro-apoptotic protein BIK.

Authors:  Suman Dalal; Qinqin Zha; Mahipal Singh; Krishna Singh
Journal:  Mol Cell Biochem       Date:  2016-06-04       Impact factor: 3.396

Review 6.  Current and future circulating biomarkers for cardiac amyloidosis.

Authors:  Marco Luciani; Luca Troncone; Federica Del Monte
Journal:  Acta Pharmacol Sin       Date:  2018-05-17       Impact factor: 6.150

Review 7.  Osteopontin and Transplantation: Where Are We Now?

Authors:  Beata Kaleta
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2021-05-21       Impact factor: 4.291

8.  Cardiac Specific Overexpression of Mitochondrial Omi/HtrA2 Induces Myocardial Apoptosis and Cardiac Dysfunction.

Authors:  Ke Wang; Yuexing Yuan; Xin Liu; Wayne Bond Lau; Lin Zuo; Xiaoliang Wang; Lu Ma; Kun Jiao; Jianyu Shang; Wen Wang; Xinliang Ma; Huirong Liu
Journal:  Sci Rep       Date:  2016-12-07       Impact factor: 4.379

9.  Effects of polyvinylpyrrolidone-iodine on tendon-bone healing in a rabbit extra-articular model.

Authors:  Peng Zhang; Yunlong Zhi; Hongwei Fang; Ziying Wu; Tianwu Chen; Jia Jiang; Shiyi Chen
Journal:  Exp Ther Med       Date:  2017-04-19       Impact factor: 2.447

10.  Expression of p53 in myocardium following coronary microembolization in rats and its significance.

Authors:  Yu-Han Sun; Qiang Su; Lang Li; Xian-Tao Wang; Yuan-Xi Lu; Jia-Bao Liang
Journal:  J Geriatr Cardiol       Date:  2017-05       Impact factor: 3.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.